Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.

Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S.

Acta Psychiatr Scand. 1992 Apr;85(4):295-305.

PMID:
1375801
2.

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.

J Clin Psychopharmacol. 1993 Feb;13(1):25-40. Erratum in: J Clin Psychopharmacol 1993 Apr;13(2):149.

PMID:
7683702
4.

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Int Clin Psychopharmacol. 2001 Nov;16(6):325-30.

PMID:
11712620
5.

Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.

Huttunen MO, Piepponen T, Rantanen H, Larmo I, Nyholm R, Raitasuo V.

Acta Psychiatr Scand. 1995 Apr;91(4):271-7.

PMID:
7542829
6.
7.

Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.

Czobor P, Volavka J.

J Clin Psychopharmacol. 1993 Oct;13(5):332-42.

PMID:
7693770
8.

Risperidone: clinical safety and efficacy in schizophrenia.

Borison RL, Pathiraja AP, Diamond BI, Meibach RC.

Psychopharmacol Bull. 1992;28(2):213-8.

PMID:
1381102
9.

[Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].

López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL Jr, González Pinto A, Eguiluz I, Fernández A.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Jul-Aug;24(4):165-72. Spanish.

PMID:
8984849
10.

The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.

Garcia E, Robert M, Peris F, Nakamura H, Sato N, Terazawa Y.

CNS Drugs. 2009;23(7):615-25. doi: 10.2165/00023210-200923070-00006.

PMID:
19552488
12.

Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.

Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD.

J Clin Psychopharmacol. 2008 Apr;28(2 Suppl 1):S29-35. doi: 10.1097/JCP.0b013e318169cca7.

PMID:
18334910
13.

Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.

Chouinard G, Kopala L, Labelle A, Beauclair L, Johnson SV, Singh KI.

Can J Psychiatry. 1998 Dec;43(10):1018-25.

PMID:
9868567
14.

Efficacy of risperidone on positive features of schizophrenia.

McEvoy JP.

J Clin Psychiatry. 1994 May;55 Suppl:18-21.

PMID:
7520904
15.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
16.

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.

Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.

Int J Neuropsychopharmacol. 2008 Nov;11(7):985-97. doi: 10.1017/S1461145708008791. Epub 2008 May 9.

PMID:
18466670
17.
18.

A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.

Laux G, Klieser E, Schröder HG, Dittmann V, Unterweger B, Schubert H, König P, Schöny HW, Bunse J, Beckmann H.

Acta Psychiatr Scand Suppl. 1990;358:125-9.

PMID:
1978471
19.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
Items per page

Supplemental Content

Write to the Help Desk